Radiofrequency ablation of primary and metastatic liver tumors.

Steven A. Curley; Francesco Izzo

Radiofrequency ablation of primary and metastatic liver tumors.

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Abstract

Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading causes of HCC. In the United States, approximately 155,000 new cases of cancer of the liver and bile duct occur annually, with the majority being colorectal metastases.

Original language	English
Pages (from-to)	99-106
Number of pages	8
Journal	Surgical technology international
Volume	10
Publication status	Published - Sep 2002

ASJC Scopus subject areas

Medicine(all)

Fingerprint Dive into the research topics of 'Radiofrequency ablation of primary and metastatic liver tumors.'. Together they form a unique fingerprint.

Cite this

@article{5434653aefbb4585a54e285a9546d7c6,

title = "Radiofrequency ablation of primary and metastatic liver tumors.",

abstract = "Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading causes of HCC. In the United States, approximately 155,000 new cases of cancer of the liver and bile duct occur annually, with the majority being colorectal metastases.",

author = "Curley, {Steven A.} and Francesco Izzo",

year = "2002",

month = sep,

language = "English",

volume = "10",

pages = "99--106",

journal = "Surgical technology international",

issn = "1090-3941",

publisher = "Universal Medical Press",

}

TY - JOUR

T1 - Radiofrequency ablation of primary and metastatic liver tumors.

AU - Curley, Steven A.

AU - Izzo, Francesco

PY - 2002/9

Y1 - 2002/9

N2 - Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading causes of HCC. In the United States, approximately 155,000 new cases of cancer of the liver and bile duct occur annually, with the majority being colorectal metastases.

AB - Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading causes of HCC. In the United States, approximately 155,000 new cases of cancer of the liver and bile duct occur annually, with the majority being colorectal metastases.

UR - http://www.scopus.com/inward/record.url?scp=34547441997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547441997&partnerID=8YFLogxK

M3 - Article

C2 - 12384870

AN - SCOPUS:34547441997

VL - 10

SP - 99

EP - 106

JO - Surgical technology international

JF - Surgical technology international

SN - 1090-3941

ER -

Radiofrequency ablation of primary and metastatic liver tumors.

Abstract

ASJC Scopus subject areas

Other files and links

Cite this